Expression of interleukin-6 in atherosclerotic lesions of male apoE- knockout mice: Inhibition by 17β-estradiol

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 9, 1998, Pages 1498-1505

  Sukovich, Drew A ^a   Kauser, Katalin ^a   Shirley, Francine D ^a   DelVecchio, Virginia ^a   Halks Miller, Meredith ^a   Rubanyi, Gabor M ^a  

^a BAYER AG   (Germany)

Author keywords

apoE knockout mice; Atherosclerosis; Estrogen; Interleukin 6

Indexed keywords

APOLIPOPROTEIN E; ESTRADIOL; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG EFFECT; FOAM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBENDOTHELIUM; T LYMPHOCYTE ACTIVATION;

EID: 0031714562     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.9.1498     Document Type: Article

References (17)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature. 1993;362:801-809.
2. Libby P, Clinton SK. The role of macrophages in atherosclerogenesis. Curr Opin Lipidol. 1993;4:355-363.
3. Raines EW, Ross R. Multiple growth factors are associated with lesions of atherosclerosis: specificity or redundancy? Bioessays. 1996;18:271-282.
4. Seino Y, Ikeda U, Ikeda M, Yamamoto K, Misawa Y, Hasegawa T, Kano S, Shimada K. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine. 1994;6:87-91.
5. Kishikawa H, Shimokama T, Watanabe T. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima: role of cell mediated immunity in human atherogenesis. Virchows Arch A Parthol Anat Histopathol. 1993;423:433-442.
6. Cochran FR, Finch-Arietta MB. Interleukin-6 can prime THP-1 macrophages for enhanced production of tumor necrosis factor-α in response to LPS. Immunopharmacology. 1992;23:97-103.
7. Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani K, Tsuruya Y, Kano S. Interleukin-6 stimulates the growth of vascular cells in a PDGF-dependent manner. Am J Physiol. 1991;260:H1713-H1717.
8. Birge SJ. The role of estrogen in the treatment of Alzheimer's disease. Neurology. 1997;48(5 suppl 7):S36-S41.
9. Samsioe G. Osteoporosis: an update. Acta Obstet Gynecol Scand. 1997;76:189-199.
10. Stampfer MJ, Colditz GA, Willet WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten year follow-up from the Nurses' Health Study. N Eng J Med. 1991;325:756-762.
11. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SC. 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest. 1992;89:883-891.
12. Pottratz ST, Bellido T, Mocharla H, Crabb D, Manolagas SC. 17β-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest. 1994;93:944-950.
13. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 1994;13:1189-1196.
14. Bourassa P-AK, Milos PM, Gaynor BJ, Breslow JL, Aiello RJ. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A. 1996;93:10022-10027.
15. Kauser K. Effect of 17β-estradiol on atherosclerotic lesion formation in ApoE-deficient mice. J Vasc Res. 1996;33(suppl 1):48. Abstract.
16. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468-471.
17. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343-353.